Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study - Concepedia

Concepedia

Publication | Open Access

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study

DOI Full Paper Access

295

Citations

18

References

2019

Year

Hiddo J.L. Heerspink, Avraham Karasik, Marcus Thuresson, Cheli Melzer Cohen, Gabriel Chodick, Kamlesh Khunti, John Wilding, Luis A. Garcı́a Rodrı́guez, Lucía Cea Soriano, Shun Kohsaka,

The Lancet Diabetes & Endocrinology

UrologyRenal DiseaseReal-world Clinical PracticeRenal FunctionKidney FailureChronic Kidney DiseaseOutcomes ResearchNephrologyMedicineEnd-stage Renal DiseaseKidney ResearchKidney OutcomesSglt2 Inhibitors

References

	Year	Citations

Page 1

Page 1